Perinatal Vaccination by Transamniotic Fetal mRNA Delivery: Immunization Against Human Cytomegalovirus in a Rodent Model
Abstract
Gestational cytomegalovirus (CMV) infection is a prevalent disease with significant fetal and neonatal morbidity. MRNA vaccines have emerged as powerful options for postnatal immunization against infections. It has been shown that mRNA delivered into the amniotic fluid reaches the fetal circulation via the placenta. We investigated whether transamniotic mRNA delivery could be a viable strategy for perinatal CMV immunization, first utilizing a rodent model.
Keywords
Congenital CytomegalovirusMrna VaccinePrenatal ImmunizationTransamniotic DeliveryMaternal-fetal MedicinePerinatal InfectionFetal TherapyHashtags
#CongenitalCMV#PrenatalVaccination#FetalTherapy#MRNAVaccineThis article is published on an external journal. Click below to read the full text.
Read full article ↗How to cite: GlobalCastMD. Perinatal Vaccination by Transamniotic Fetal mRNA Delivery: Immunization Against Human Cytomegalovirus in a Rodent Model. GlobalCastMD Medical Library. 2024-09-23. https://library.globalcastmd.com/article/9197
Comments (0)